The Global Membrane Oxygenators Market was valued at USD 133.8 million in 2025 and is estimated to grow at a CAGR of 2.4% to reach USD 167.5 million by 2035.
The market is expanding due to the rising incidence of respiratory and cardiac disorders, including conditions such as ARDS, cardiogenic shock, and myocarditis. Membrane oxygenators serve a critical role in extracorporeal life support, facilitating gas exchange by removing carbon dioxide and delivering oxygen to the blood. Advanced designs utilizing hollow fiber and flat sheet membranes are essential in managing respiratory and cardiac failure, particularly during ECMO procedures. Increasing adoption of ECMO in critical care, supported by growing healthcare spending and enhanced infrastructure in developing regions, is driving demand. Government initiatives to improve access to ECMO training, alongside the development of portable and user-friendly devices, are broadening the application of membrane oxygenators, particularly in neonatal and pediatric care. Enhanced efficiency, safety, and adaptability are key drivers shaping market growth globally.
The hollow fiber membrane oxygenators segment is expected to grow at a CAGR of 2.7% to reach USD 103.9 million by 2035. Hollow fiber systems are preferred for their compact design, superior gas exchange efficiency, and compatibility with critical care procedures, including cardiopulmonary bypass and ECMO. Technological advancements enhancing biocompatibility and reducing blood trauma further strengthen their adoption, particularly in neonatal and pediatric applications, where patient size and safety are critical.
The hospitals segment held a 44.1% share in 2025. Hospitals remain primary users of membrane oxygenators due to their role in managing critical conditions such as ARDS, cardiogenic shock, and post-cardiac surgery care. The increasing number of cardiovascular and respiratory cases, combined with specialized infrastructure and trained staff, supports the rising demand for ECMO procedures. Integration of advanced ECMO systems in ICUs improves patient outcomes, reinforcing the critical role of hospitals in market expansion.
U.S. Membrane Oxygenators Market was valued at USD 44.4 million in 2025. A rising prevalence of respiratory and cardiovascular diseases, an aging population, and increasing chronic health conditions are driving the adoption of ECMO procedures that rely on membrane oxygenators. A strong healthcare infrastructure, the proliferation of ECMO centers, and technological improvements in portable and efficient oxygenators support demand, especially in neonatal and pediatric care applications.
Prominent players in the Global Membrane Oxygenators Market include Abbott, BRAILE, Chalice, CytoSorbents, EUROSETS, Fresenius, GETINGE, LivaNova, Medtronic, MicroPort, NIPRO, PrecisionMedical, RECTUS MEDICAL, TERUMO, and XENIOS. Companies in the Global Membrane Oxygenators Market adopt strategies such as investing in R&D to improve membrane biocompatibility and gas exchange efficiency, expanding product lines to include portable and neonatal-friendly oxygenators, and forming strategic partnerships with hospitals and ECMO centers to strengthen distribution channels. They also focus on regulatory compliance and clinical validation to enhance credibility and market trust. Targeted marketing campaigns, training programs for healthcare professionals, and participation in global medical expos help boost brand recognition. In addition, companies pursue mergers and acquisitions to consolidate technological capabilities, reduce competition, and expand their regional footprint across North America, Europe, and Asia-Pacific, ensuring long-term market presence and sustained growth.
This product will be delivered within 2-4 business days.
The market is expanding due to the rising incidence of respiratory and cardiac disorders, including conditions such as ARDS, cardiogenic shock, and myocarditis. Membrane oxygenators serve a critical role in extracorporeal life support, facilitating gas exchange by removing carbon dioxide and delivering oxygen to the blood. Advanced designs utilizing hollow fiber and flat sheet membranes are essential in managing respiratory and cardiac failure, particularly during ECMO procedures. Increasing adoption of ECMO in critical care, supported by growing healthcare spending and enhanced infrastructure in developing regions, is driving demand. Government initiatives to improve access to ECMO training, alongside the development of portable and user-friendly devices, are broadening the application of membrane oxygenators, particularly in neonatal and pediatric care. Enhanced efficiency, safety, and adaptability are key drivers shaping market growth globally.
The hollow fiber membrane oxygenators segment is expected to grow at a CAGR of 2.7% to reach USD 103.9 million by 2035. Hollow fiber systems are preferred for their compact design, superior gas exchange efficiency, and compatibility with critical care procedures, including cardiopulmonary bypass and ECMO. Technological advancements enhancing biocompatibility and reducing blood trauma further strengthen their adoption, particularly in neonatal and pediatric applications, where patient size and safety are critical.
The hospitals segment held a 44.1% share in 2025. Hospitals remain primary users of membrane oxygenators due to their role in managing critical conditions such as ARDS, cardiogenic shock, and post-cardiac surgery care. The increasing number of cardiovascular and respiratory cases, combined with specialized infrastructure and trained staff, supports the rising demand for ECMO procedures. Integration of advanced ECMO systems in ICUs improves patient outcomes, reinforcing the critical role of hospitals in market expansion.
U.S. Membrane Oxygenators Market was valued at USD 44.4 million in 2025. A rising prevalence of respiratory and cardiovascular diseases, an aging population, and increasing chronic health conditions are driving the adoption of ECMO procedures that rely on membrane oxygenators. A strong healthcare infrastructure, the proliferation of ECMO centers, and technological improvements in portable and efficient oxygenators support demand, especially in neonatal and pediatric care applications.
Prominent players in the Global Membrane Oxygenators Market include Abbott, BRAILE, Chalice, CytoSorbents, EUROSETS, Fresenius, GETINGE, LivaNova, Medtronic, MicroPort, NIPRO, PrecisionMedical, RECTUS MEDICAL, TERUMO, and XENIOS. Companies in the Global Membrane Oxygenators Market adopt strategies such as investing in R&D to improve membrane biocompatibility and gas exchange efficiency, expanding product lines to include portable and neonatal-friendly oxygenators, and forming strategic partnerships with hospitals and ECMO centers to strengthen distribution channels. They also focus on regulatory compliance and clinical validation to enhance credibility and market trust. Targeted marketing campaigns, training programs for healthcare professionals, and participation in global medical expos help boost brand recognition. In addition, companies pursue mergers and acquisitions to consolidate technological capabilities, reduce competition, and expand their regional footprint across North America, Europe, and Asia-Pacific, ensuring long-term market presence and sustained growth.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Age Group, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Membrane Oxygenators market report include:- Abbott
- BRAILE
- chalice
- CytoSorbents
- EUROSETS
- Fresenius
- GETINGE
- LivaNova
- Medtronic
- MicroPort
- NIPRO
- PrecisionMedical
- RECTUS MEDICAL
- TERUMO
- XENIOS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 133.8 Million |
| Forecasted Market Value ( USD | $ 167.5 Million |
| Compound Annual Growth Rate | 2.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
